KRSNAA

Krsnaa Diagnostics Limited

PPP-led integrated radiology and pathology platform

Healthcare›Healthcare›Healthcare Services›Healthcare Service Provider

krsnaadiagnostics.com(opens the company website in a new tab)
Ask AI

Key metrics

Price as of 2026-10-16

Stock price
₹533.30
Market cap
1,731 Cr
Stock P/E
17.8
P/B
1.76
Dividend yield
0.5%
ROE (FY26)
10.3%
ROCE (FY26)
10.9%
Operating margin (FY26)
15.7%
Debt / equity (FY26)
0.55
OCF / EBITDA (FY26)
67.5%
OCF / EBITDA (3Y)
46.6%

Full years shown; sign in free for the trailing twelve months. Learn about these metrics →

Price & valuation

Share price and valuation multiples (P/E, P/B and more) over time.

Loading price history…

Compare with peers

Loading peers…

What you need to know

KRSNAA (Krsnaa Diagnostics) runs radiology and pathology diagnostic centres and laboratories, mainly under public-private partnership contracts with government, and is growing a retail diagnostics business alongside.

Company snapshot

6thBy market cap

Ranked among 10 companies in Healthcare Service Provider.

What we see

Concerns
  • ✗Only 47% of operating profit came in as cash over the last three years — much of it is tied up in unpaid bills or stock.

Statement tables · Consolidated

Switches quarterly, P&L, balance sheet, and cash flow. Key metrics and ratios stay on consolidated when available.

Amounts in ₹ Cr · tap + to expand rows

Quarterly results

Quarterly · ₹ Cr · tap + rows to expand

MetricSept 2023Dec 2023Mar 2024Jun 2024Sept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026Jun 2026
Sales155 Cr158 Cr166 Cr170 Cr186 Cr175 Cr186 Cr193 Cr206 Cr181 Cr193 Cr236 Cr
Operating expenses (approx.)124 Cr121 Cr123 Cr128 Cr137 Cr129 Cr133 Cr142 Cr147 Cr135 Cr138 Cr178 Cr
EBITDA32 Cr37 Cr44 Cr43 Cr49 Cr45 Cr53 Cr51 Cr59 Cr46 Cr55 Cr58 Cr
OPM %20.4%23.6%26.3%25.1%26.5%25.8%28.5%26.6%28.7%25.6%28.5%24.6%
Other income4 Cr4 Cr4 Cr7 Cr5 Cr9 Cr4 Cr4 Cr4 Cr4 Cr31 Cr7 Cr
Interest3 Cr4 Cr7 Cr5 Cr6 Cr6 Cr7 Cr6 Cr8 Cr8 Cr12 Cr15 Cr
Depreciation19 Cr21 Cr18 Cr21 Cr22 Cr23 Cr22 Cr22 Cr24 Cr23 Cr23 Cr28 Cr
Profit before tax13 Cr16 Cr23 Cr23 Cr25 Cr25 Cr29 Cr27 Cr32 Cr20 Cr52 Cr22 Cr
Tax %21.8%19.4%17.2%22.8%22.9%23.8%27.7%25.2%24.1%22.5%19.3%26.2%
Net profit10 Cr13 Cr19 Cr18 Cr20 Cr19 Cr21 Cr21 Cr24 Cr15 Cr42 Cr17 Cr
EPS (₹)₹3.35₹4.09₹5.80₹5.55₹6.07₹6.01₹6.40₹6.35₹7.38₹4.72₹12.86₹5.10

Profit & loss (annual)

Annual · last column is TTM · ₹ Cr · tap + to expand

MetricMar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales455 Cr487 Cr620 Cr717 Cr773 CrSign in free for the trailing twelve months
Operating expenses (approx.)324 Cr365 Cr475 Cr527 Cr561 CrSign in free for the trailing twelve months
EBITDA131 Cr122 Cr144 Cr190 Cr212 CrSign in free for the trailing twelve months
OPM %28.9%25.1%23.3%26.5%27.4%Sign in free for the trailing twelve months
Other income15 Cr19 Cr17 Cr26 Cr43 CrSign in free for the trailing twelve months
Interest18 Cr8 Cr16 Cr25 Cr34 CrSign in free for the trailing twelve months
Depreciation41 Cr54 Cr75 Cr88 Cr90 CrSign in free for the trailing twelve months
Profit before tax87 Cr80 Cr70 Cr103 Cr130 CrSign in free for the trailing twelve months
Tax %20.9%22.6%18.8%24.4%22.2%Sign in free for the trailing twelve months
Net profit68 Cr62 Cr57 Cr78 Cr101 CrSign in free for the trailing twelve months
EPS (₹)₹22.89₹19.78₹17.90₹24.04₹31.30Sign in free for the trailing twelve months
Dividend payout %0.0%12.6%15.2%10.4%8.8%Sign in free for the trailing twelve months
Sign in free for the trailing twelve months

The latest four quarters added up, next to each full year

Balance sheet

Annual · ₹ Cr · tap + rows to expand

MetricMar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity capital16 Cr16 Cr16 Cr16 Cr16 Cr
Reserves669 Cr723 Cr794 Cr867 Cr964 Cr
Borrowings41 Cr32 Cr160 Cr204 Cr534 Cr
Other liabilities151 Cr139 Cr202 Cr195 Cr309 Cr
Total liabilities876 Cr910 Cr1,172 Cr1,282 Cr1,824 Cr
Fixed assets (net)383 Cr468 Cr645 Cr667 Cr652 Cr
CWIP28 Cr25 Cr10 Cr3 Cr208 Cr
Investments0.29 Cr0.29 Cr0.29 Cr32 Cr57 Cr
Inventories9 Cr25 Cr36 Cr29 Cr27 Cr
Trade receivables58 Cr73 Cr176 Cr278 Cr296 Cr
Cash & bank88 Cr23 Cr2 Cr4 Cr30 Cr
Other assets309 Cr295 Cr303 Cr269 Cr554 Cr
Total assets876 Cr910 Cr1,172 Cr1,282 Cr1,824 Cr

Cash flows

Annual · ₹ Cr · tap + rows to expand · last column includes FCF

MetricMar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Cash from operating activity128 Cr76 Cr24 Cr87 Cr143 Cr
Cash from investing-241 Cr-109 Cr-129 Cr-100 Cr-396 Cr
Cash from financing176 Cr-33 Cr84 Cr14 Cr279 Cr
Net cash flow64 Cr-66 Cr-20 Cr1 Cr26 Cr
Free cash flow (OCF − Capex)-4 Cr-65 Cr-170 Cr-39 Cr-76 Cr

Ratios

MetricMar 2022Mar 2023Mar 2024Mar 2025Mar 2026
ROCE %14.5%11.4%8.9%11.7%10.9%
ROE %10.0%8.4%7.0%8.8%10.3%
Debtor days4655104141139
Inventory days55123936354
Days payable467305213209128
Cash conversion cycle-365-127-17-565
OCF / EBITDA %97.7%62.4%16.9%45.9%67.5%
OCF / EBITDA % (3 years)——57.6%41.2%46.6%
Debt / equity0.060.040.200.230.55
Current ratio2.252.281.501.362.68
Net debt / EBITDA-0.360.081.091.052.38